Reducing the risks of prenatal opioid exposure in children
BMJ
.
2024 Apr 24:385:q803.
doi: 10.1136/bmj.q803.
Authors
Xuerong Wen
1
,
Todd Brothers
2
,
Kristina E Ward
2
,
Stephen Kogut
2
Affiliations
1
Pharmacy Practice and Clinical Research, College of Pharmacy, University of Rhode Island, Kingston, RI, USA xuerongwen@uri.edu.
2
Pharmacy Practice and Clinical Research, College of Pharmacy, University of Rhode Island, Kingston, RI, USA.
PMID:
38658037
DOI:
10.1136/bmj.q803
No abstract available
Publication types
Editorial
MeSH terms
Analgesics, Opioid* / adverse effects
Child
Female
Humans
Opioid-Related Disorders / prevention & control
Pregnancy
Prenatal Exposure Delayed Effects* / prevention & control
Substances
Analgesics, Opioid